Product Information
PROGESTERONE 500 MG/10 ML VIAL is a generic product labeled by Actavis Pharma, Inc., priced at $1.3605 per ML under NDC 00591312879. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
50 mg/mL
Manufacturer
Actavis Pharma, Inc.NDC
00591312879
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
PROGESTERONEApproval Type
New Drug (NDA)
FDA Application
NDA017362FDA Approved
Before 1982
On Market Since
5/11/1978
Pharmacological Classes
Price Statistics
The NADAC for PROGESTERONE 500 MG/10 ML VIAL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3605 per ML |
|---|---|
| All-time high | $2.9078 (May 13, 2020) |
| All-time low | $0.9264 (May 22, 2024) |
| 52-week high | $1.6930 |
| 52-week low | $1.3605 |
| Median price | $2.2734 |
| Average price | $2.1648 |
| Largest weekly change | +55.4% (Apr 22, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PROGESTERONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progesterone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROGESTERONE 500 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for PROGESTERONE 500 MG/10 ML VIAL, manufactured by Actavis Pharma, Inc., is $1.3605 per ML (NDC 00591312879), effective Sep 30, 2026.
How has the price of PROGESTERONE 500 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for PROGESTERONE 500 MG/10 ML VIAL has declined 48.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROGESTERONE 500 MG/10 ML VIAL?
Since Nov 28, 2013, the NADAC for PROGESTERONE 500 MG/10 ML VIAL has ranged from a low of $0.9264 (May 22, 2024) to a high of $2.9078 (May 13, 2020), with a median of $2.2734 per ML.
Are there cheaper alternatives to PROGESTERONE 500 MG/10 ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROGESTERONE 500 MG/10 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures PROGESTERONE 500 MG/10 ML VIAL?
PROGESTERONE 500 MG/10 ML VIAL (NDC 00591312879) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.